
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is facing challenges in its current quarterly results, however, the company's strong sales in its flagship product and plans for capitalizing on new markets show promising growth potential. The company's current undervalued stock also presents an attractive opportunity for investors. With a focus on expansion and profitability, Synergy CHC's track record and future plans make it a recommended investment choice with a projected 12-month price target of $5.
Bears say
Synergy CHC is facing several risks that could limit its future growth and profitability, including a high level of debt, changes in demand for health and wellness products, competition, and changing consumer trends. Its recent partnership termination and volatile stock performance also signal potential instability. However, the company has a solid distribution network and a range of popular products, and may see growth potential in new markets and product expansions. It will be important for the company to manage its financials effectively and continue to diversify and expand its brand offerings in order to mitigate risks and achieve success.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares